Blueberries Medical Corp. BBM

BBM Company Overview

Blueberries Medical Corp. (CSE: BBM) is a Canadian-based cannabis company focused on the cultivation, processing, and commercialization of medicinal cannabis and cannabis-derived products, primarily in Latin America. The company operates in the pharmaceutical and medical cannabis industries, with an emphasis on low-cost production in Colombia and the development of cannabinoid-based products for domestic and export markets. Its business model has historically centered on leveraging Colombia’s climate and agricultural conditions to produce cannabis biomass and extracts at comparatively lower operating costs than producers in North America and Europe.

The company’s primary revenue drivers have included the cultivation of cannabis flower, extraction activities, and the development of medical cannabis formulations intended for pharmaceutical and wellness applications. Blueberries Medical has positioned itself around vertically integrated cannabis operations, including cultivation infrastructure and extraction capabilities. Public disclosures indicate that the company evolved from a broader cannabis cultivation strategy into a more focused medicinal cannabis platform targeting regulated international markets. Data regarding recent commercial scale and revenue contribution by individual product category is limited in current public disclosures, and some operational details are inconclusive based on available public sources.